Back to SNDX
Catalio Capital Management, LP → SNDX
Catalio Capital Management, LP SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$26.6M
Q2 2026
Peak value
$26.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $24.8M |
| Q4 2025 | $25.1M |
| Q4 2025 | $25.1M |
| Q1 2026 | $24.4M |
| Q2 2026 | $26.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $26.6M | 1.22M | — | — |
| Q1 2026 | $24.4M | 1.04M | — | — |
| Q4 2025 | $25.1M | 1.20M | — | — |
| Q4 2025 | $25.1M | 1.20M | — | — |
| Q3 2025 | $24.8M | 1.61M | — | — |
Other funds holding SNDX
$123.7M
$123.7M
$118.9M
$116.1M
$114.7M
$114.2M
$114.2M
$111.4M